ϰϲͼ

header-logo
Research Collaborate Lab Hall

Working with Controlled Substances at the ϰϲͼ

The vast majority of controlled substances at the ϰϲͼ are employed in the use and care of research animals (e.g. analgesia or anesthesiology). In rarer cases, researchers use controlled substances in vitro or in vivo involving tissues, animals, or human subjects. It is imperative that acquisition, use, storage, and disposal of controlled substances conform to Federal and State laws.

Frequently Asked Questions

all
What is a controlled substance?

Drugs and other substances that are considered controlled substances under the Controlled Substances Act of 1970 are divided into five schedules. A listing of the substances and their schedules can be found at the U.S. Department of Justice Drug Enforcement Agency Office of Diversion Control .

What approvals do I need to work with controlled substances?

For conducting research on narcotic and non-narcotic controlled substances in Schedules II-IV,  is submitted with the following information required:

  1. Investigator - Name, address, institution, state license, and a qualifications statement including a curriculum vita with bibliography for each investigator in the research project.
  2. Project - Title, statement of purpose, controlled substance name, amount needed, location of research, security statement and a technical description of the substance use.
  3. Form #225A is used to renew this registration.

In addition to the Federal license, ϰϲͼ researchers must obtain a State of Wisconsin Special Use Authorization permit. Directions can be found at the Wisconsin Department of Safety and Professional Services (PDF). Additional information is available at .

What can I do to streamline the approval process?
  • Order controlled substances through ϰϲͼ Purchasing. For investigators who have access to the ϰϲͼ intranet site InfoScope, select “Purchasing” from the A-Z directory to visit the Accounts Payable & Purchasing Department website.
  • Ensure you have all of the requirements established before applying for State or federal licensing.
  • Confer with colleagues who have applied and hold both State and Federal licenses.
Is auditing or monitoring required?

ϰϲͼ has an obligation to audit acquisition, use, record keeping, inventory, storage, transfer, and disposal of all controlled substances used in research at all ϰϲͼ owned, leased, or otherwise occupied facilities per ϰϲͼ Corporate Policy Use and Storage of Controlled Substances (RS.GS.020). 

Contact the for additional information. 

What can I do to prevent problems in the laboratory?
  • Secure controlled substances in an approved, limited access drug safe.
  • Maintain an accurate and up to date inventory of each drug.
  • Never abandon a controlled substance. The registrant who procured the controlled substance is responsible for life for that drug (unless paperwork for a transfer to another authorized registrant exists) and will be subject to penalties by State and Federal authorities.
What training is required?

No training is required. The process of obtaining a identifies requirements and steps.

What are the relevant policies and guidelines?

Registrants must comply with:

  • Drug Enforcement Agency (DEA) ;
  • All related laws in the Congressional Federal record;
  • The State of Wisconsin Pharmaceutical Board;
  • ϰϲͼ Corporate Policy Use and Storage of Controlled Substances (RS.GS.020)
Who do I contact if I have additional questions?

The Controlled Substances Coordinator is available to answer most questions and is the point of contact with the local DEA Diversion Office:

(414) 955-8274

public_fsc@mcw.edu